Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N91021F00017
SUPPORT SERVICES (BIOLOGIST 21/22/23) FOR THE LABORATORY OF GENOME INTEGRITY, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE NCIOA-TSB-SSS-071
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541712 |
| PSC | R431 — SUPPORT- PROFESSIONAL: HUMAN RESOURCES |
| Parent award / vehicle | HHSN261201700002B |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $427.4K |
| Current contract value | $427.4K |
| Potential contract value / ceiling | $427.4K |
| Start date | Nov 16, 2020 |
| Current end date | Nov 15, 2023 |
| Potential end date | Nov 15, 2023 |
| Latest award activity | Jul 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 23, 2026 | P00003 | $-42.0K | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| Nov 15, 2022 | P00002 | $160.2K | SUPPORT SERVICES (BIOLOGIST 21/22/23) FOR THE LABORATORY OF GENOME INTEGRITY, CCR. OPTION PERIOD 1: 11/16/21-11/15/22 |
| Nov 10, 2021 | P00001 | $156.4K | SUPPORT SERVICES (BIOLOGIST 21/22/23) FOR THE LABORATORY OF GENOME INTEGRITY, CCR. OPTION PERIOD 1: 11/16/21-11/15/22 |
| Nov 5, 2020 | 0 | $152.7K | SUPPORT SERVICES (BIOLOGIST 21/22/23) FOR THE LABORATORY OF GENOME INTEGRITY, CENTER FOR CANCER RESEARCH, NATIONAL CANCER INSTITUTE NCIOA-TSB-SSS-071 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.